These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 12184735)
1. Different effects of oral administration of synthetic trypsin inhibitor on the pancreas between cholecystokinin-A receptor gene knockout mice and wild type mice. Sato N; Suzuki S; Kanai S; Ohta M; Jimi A; Noda T; Takiguchi S; Funakoshi A; Miyasaka K Jpn J Pharmacol; 2002 Jul; 89(3):290-5. PubMed ID: 12184735 [TBL] [Abstract][Full Text] [Related]
2. Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats. Jia D; Taguchi M; Otsuki M Pancreas; 2005 Jan; 30(1):54-61. PubMed ID: 15632700 [TBL] [Abstract][Full Text] [Related]
3. Different effects of trypsin inhibitors on intestinal gene expression of secretin and on pancreatic bicarbonate secretion in CCK-A-receptor-deficient rats. Kawanami T; Suzuki S; Yoshida Y; Kanai S; Takata Y; Shimazoe T; Watanabe S; Funakoshi A; Miyasaka K Jpn J Pharmacol; 1999 Dec; 81(4):339-45. PubMed ID: 10669038 [TBL] [Abstract][Full Text] [Related]
4. CCK-induced pancreatic growth is not limited by mitogenic capacity in mice. Crozier SJ; Sans MD; Lang CH; D'Alecy LG; Ernst SA; Williams JA Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1148-57. PubMed ID: 18356533 [TBL] [Abstract][Full Text] [Related]
5. Induction of early response genes in trypsin inhibitor-induced pancreatic growth. Guo L; Sans MD; Gurda GT; Lee SH; Ernst SA; Williams JA Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G667-77. PubMed ID: 17095753 [TBL] [Abstract][Full Text] [Related]
6. Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas. Koop I; Lindenthal M; Schade M; Trautmann M; Adler G; Arnold R Pancreas; 1991 Sep; 6(5):564-70. PubMed ID: 1946314 [TBL] [Abstract][Full Text] [Related]
7. Effects of camostat, a synthetic protease inhibitor, on endocrine and exocrine pancreas of the rat. Müller MK; Goebell H; Alfen R; Ehlers J; Jäger M; Plümpe H J Nutr; 1988 May; 118(5):645-50. PubMed ID: 2452864 [TBL] [Abstract][Full Text] [Related]
8. CCK-58 is the only detectable endocrine form of cholecystokinin in rat. Reeve JR; Green GM; Chew P; Eysselein VE; Keire DA Am J Physiol Gastrointest Liver Physiol; 2003 Aug; 285(2):G255-65. PubMed ID: 12686511 [TBL] [Abstract][Full Text] [Related]
9. Calcineurin mediates pancreatic growth in protease inhibitor-treated mice. Tashiro M; Samuelson LC; Liddle RA; Williams JA Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G784-90. PubMed ID: 14684381 [TBL] [Abstract][Full Text] [Related]
10. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice. Niederau C; Liddle RA; Williams JA; Grendell JH Gut; 1987; 28 Suppl(Suppl):63-9. PubMed ID: 2446964 [TBL] [Abstract][Full Text] [Related]
11. Mediation of trypsin inhibitor-induced pancreatic hypersecretion by secretin and cholecystokinin in rats. Watanabe S; Takeuchi T; Chey WY Gastroenterology; 1992 Feb; 102(2):621-8. PubMed ID: 1732130 [TBL] [Abstract][Full Text] [Related]
12. Precocious alteration of digestive enzyme activities in small intestine and pancreas by chronic oral administration of protease inhibitor in suckling rats. Harada E; Syuto B Comp Biochem Physiol A Comp Physiol; 1991; 100(2):467-72. PubMed ID: 1685962 [TBL] [Abstract][Full Text] [Related]
13. Role of CCK-A receptor for pancreatic function in mice: a study in CCK-A receptor knockout mice. Takiguchi S; Suzuki S; Sato Y; Kanai S; Miyasaka K; Jimi A; Shinozaki H; Takata Y; Funakoshi A; Kono A; Minowa O; Kobayashi T; Noda T Pancreas; 2002 Apr; 24(3):276-83. PubMed ID: 11893936 [TBL] [Abstract][Full Text] [Related]
14. Chronic oral administration of protease inhibitor decreases CCK-A receptor mRNA expression but increases pancreatic growth in rats. Fukumitsu K; Nakamura H; Otsuki M Pancreas; 2001 Mar; 22(2):179-85. PubMed ID: 11249073 [TBL] [Abstract][Full Text] [Related]
15. Effect of a new CCK-A receptor antagonist, dexloxiglumide, on the exocrine pancreas in the rat. Varga G; Kisfalvi K; D'Amato M; Scarpignato C J Physiol Paris; 1997; 91(3-5):257-64. PubMed ID: 9403804 [TBL] [Abstract][Full Text] [Related]
16. Oral administration of a synthetic trypsin inhibitor increases pancreatic duct function in CCK-A receptor-deficient rats. Kawanami T; Funakoshi A; Suzuki S; Kanai S; Sato Y; Miyasaka K Pancreas; 2000 May; 20(4):394-400. PubMed ID: 10824695 [TBL] [Abstract][Full Text] [Related]
17. The effect of endogenous cholecystokinin released by bombesin and trypsin inhibitor on the regeneration of the pancreas. Parekh D; Ishizuka J; Townsend CM; Rajaraman S; Thompson JC Ann Surg; 1993 Dec; 218(6):735-41. PubMed ID: 8257223 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of proteinase inhibitor camostat on exocrine pancreas in fed and fasted rats. Otsuki M; Tani S; Fujii M; Nakamura T; Okabayashi Y; Koide M Am J Physiol; 1993 Oct; 265(4 Pt 2):R896-901. PubMed ID: 7694489 [TBL] [Abstract][Full Text] [Related]
19. Disruption of cholecystokinin (CCK)-B receptor gene did not modify bile or pancreatic secretion or pancreatic growth: a study in CCK-B receptor gene knockout mice. Miyasaka K; Shinozaki H; Suzuki S; Sato Y; Kanai S; Masuda M; Jimi A; Nagata A; Matsui T; Noda T; Kono A; Funakoshi A Pancreas; 1999 Aug; 19(2):114-8. PubMed ID: 10438156 [TBL] [Abstract][Full Text] [Related]
20. Changes in pattern of enzyme secretion by rat pancreas during repeated trypsin inhibitor treatment. Keim V; Göke B; Adler G Am J Physiol; 1988 Aug; 255(2 Pt 1):G236-41. PubMed ID: 2457325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]